A clever new set of glasses may offer new hope to people with macular degeneration. By copying the structure of a fly's eyes, ...
Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...
US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...
Lutein plays a pivotal role in safeguarding the eyes by filtering blue light, which can penetrate deep into the eye and ...
Developed by Soliddd Corp, this innovative technology, showcased at CES 2025, represents the “first true vision correction” ...
Plowright brought stage and screen characters to vibrant life for more than six decades in such works as A Taste of Honey, ...
Physical changes are a normal byproduct of aging. Gray hairs and less elastic skin that contributes to wrinkles may be among ...
Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025.
EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® 20.01.2025 / ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback